
The Lancet | The best science for better lives
The Lancet sets extremely high standards. We select only the best research papers for their quality of work and the progression they bring.
The Lancet: Journal Homepage
2 days ago · Explore articles from The Lancet, a world-leading medical journal founded in 1823, committed to applying scientific knowledge to improve health and advance human progress
The Lancet, 02 May 2026, Volume 407, Issue 10540, Pages 1657-1756
2 days ago · Explore the current issue of The Lancet, a world leading medical journal published weekly since 1823
Online First - The Lancet
4 days ago · Explore the latest articles from The Lancet, published online ahead of print
The 2025 report of the Lancet Countdown on health and climate …
Authored by 128 multidisciplinary experts worldwide, the 2025 report of the Lancet Countdown on health and climate change is the ninth—and most comprehensive—assessment of the links between …
Global, regional, and national burden of chronic kidney ... - The Lancet
Nov 7, 2025 · CKD is a major global health issue, with rising prevalence and increasing importance as a cause of death and as a risk factor for cardiovascular death. A better understating of aetiology, …
Open Access - The Lancet
Jan 1, 2026 · The right to health, health equity, and social justice requires that the best evidence be shared as widely as possible to inform change. Open access is a central component of open …
The Lancet Oncology
Apr 9, 2026 · Access articles from The Lancet Oncology, covering topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology
Semaglutide and cardiovascular outcomes by baseline and ... - The …
Nov 8, 2025 · The cardioprotective effects of semaglutide were independent of baseline adiposity and weight loss and had only a small association with waist circumference, suggesting some …
Assessment of adverse effects attributed to statin therapy ... - The Lancet
Feb 5, 2026 · Adverse event data from blinded randomised trials do not support causal relationships between statin therapy and most of the conditions (including cognitive impairment, depression, sleep …